After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Supernus Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Supernus Pharmaceuticals Inc is $1.83B. A total of 1.5 million shares were traded on the day, compared to an average of 566.21K shares.
In the most recent transaction, Rubin Jonathan sold 927 shares of SUPN for 39.15 per share on Feb 21 ’25. After the transaction, the SVP, Chief Medical Officer now owns 7,853 company shares. In a previous transaction on Feb 04 ’25, Bhatt Padmanabh P. sold 9,477 shares at 39.70 per share. SUPN shares that Sr. VP of IP, CSO owns now total 10,149.
Among the insiders who sold shares, Bhatt Padmanabh P. disposed of 2,573 shares on Jan 27 ’25 at a per-share price of $39.62. This resulted in the Sr. VP of IP, CSO holding 10,149 shares of SUPN after the transaction. In another insider transaction, Bhatt Padmanabh P. sold 700 shares at $39.62 per share on Jan 28 ’25. Company shares held by the Sr. VP of IP, CSO now total 10,149.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, SUPN has a high of $40.28 and a low of $25.53.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. SUPN’s latest balance sheet shows that the firm has $339.68M in Cash & Short Term Investments as of fiscal 2021. There were $427.03M in debt and $315.38M in liabilities at the time. Its Book Value Per Share was $18.58, while its Total Shareholder’s Equity was $815.85M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SUPN is Buy with a score of 3.80.
